http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16315018

Outgoing Links

Predicate Object
contentType Journal Article
issn 1664-3224
pageRange 17-
publicationName Frontiers in Immunology
startingPage 17
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fc6b2ebfbea1710e5eebd4afbc04fa64
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e6e60f992a18c1d86feae8b40b3ed48a
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_42a9c6fa8b4c91bb4ac4fbd5bfcb998f
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3e2f00ec14dd857beab999318a13bcd5
bibliographicCitation Shields AM, Panayi GS, Corrigall VM. A New-Age for Biologic Therapies: Long-Term Drug-Free Therapy with BiP? Front Immunol. 2012;3():17. PMID: 22566902; PMCID: PMC3342250.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfe5f678cefc89304a20377a35cd5f57
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bfb13de50773dfd3963416c0039395f7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bff225b1d9598eea013cf7edded98711
date 2012
identifier https://pubmed.ncbi.nlm.nih.gov/PMC3342250
https://pubmed.ncbi.nlm.nih.gov/22566902
https://doi.org/10.3389/fimmu.2012.00017
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39309
https://portal.issn.org/resource/ISSN/1664-3224
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title A New-Age for Biologic Therapies: Long-Term Drug-Free Therapy with BiP?
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d93bea4c204c506cd3825c16020d3f10
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f9f6b8975c3c5fc96e3b5133a6012c07
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128363760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129328711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128684338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433

Total number of triples: 31.